Physician profile
Matthew Spinks
NPI 1861704108
$1,219.08
in general payments reported to CMS, 2019-2025
12 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.03 · 2021: $61.16 · 2022: $17.33 · 2024: $370 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $432.62 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbott Laboratories | $180.53 | 2024-2025 | Eterna |
| Boston Scientific Corporation | $149.43 | 2025 | General - Pain Management, Intracept |
| Ipsen Biopharmaceuticals, INC | $100.24 | 2024 | Dysport |
| Mml US, INC. | $86.89 | 2025 | Reactiv8 |
| Medtronic USA, INC. | $74.03 | 2019 | |
| Allergan, INC. | $54.82 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $41.47 | 2021-2025 | Belbuca |
| Globus Medical, INC. | $39.04 | 2025 | Senza |
| Spr Therapeutics, INC | $20.51 | 2024 | Sprint Pns System |
| Valinor Pharma, LLC | $19.76 | 2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.74 | 2024 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Spinks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.